EXICURE INC XCUR
COM NEW · Common Stock · CUSIP 30205M200
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersChicago, IL
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.20.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 19 |
| Q4 2022 | 17 |
| Q1 2023 | 16 |
| Q2 2023 | 16 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 7 |
| Q1 2023 | 5 | 7 |
| Q2 2023 | 4 | 7 |
Biggest buyers
| CITADEL ADVISORS LLC | New | +50.4k |
| ROYAL BANK OF CANADA | Added | +83 |
| BlackRock Inc. | Added | +44 |
| WELLS FARGO & COMPANY/MN | Added | +27 |
Biggest sellers
| Carlson Capital, L.P. | Reduced | -64.1k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -10.6k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -3.2k |
| Tower Research Capital LLC (TRC) | Reduced | -2.5k |
| OSAIC HOLDINGS, INC. | Reduced | -1.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -585 |
| UBS Group AG | Reduced | -86 |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 1 | $279.7k | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Carlyle Group Inc. 0.01% of their portfolio | 281.6k $368.9k | Unchanged |
| Carlson Capital, L.P. 0.01% of their portfolio | 125.0k $163.8k | Reduced -64.1k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 62.9k $82.0k | Reduced -3.2k |
| NORTHWESTERN UNIVERSITY 0.00% of their portfolio | 52.1k $68 | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 50.4k $66.0k | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 34.3k $45.0k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 21.6k $28.4k | Reduced -585 |
| BlackRock Inc. 0.00% of their portfolio | 12.3k $16.1k | Added +44 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 6.8k $8.9k | Reduced -2.5k |
| MORGAN STANLEY 0.00% of their portfolio | 3.4k $4.4k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 1.8k $2.4k | Reduced -86 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 289 $378 | Reduced -1.6k |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 163 $0 | Added +83 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 50 $65 | Added +27 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 10 $13 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |